The consultation on raising the threshold suggests that this change will “ensure that the BIT continues to target those ...

MERGE announces new Chair. MERGE, a Chicago-based integrated technology and marketing services provider, has a new board ...

US Senator Elizabeth Warren has asked the Federal Trade Commission (FTC) to look into a $16.5 billion deal that would give ...

Novartis' Piqray/Vijoice (alpelisib) is the only PIK3CA inhibitor to have reached the market for breast cancer, having been ...

In another twist to the tale of Starboard Value's push for change at Pfizer, the activist investor has claimed former ...

Rumours that Sanofi was in discussion with private equity groups over the sale of its consumer health business Opella have been confirmed – at least partially. The French pharma group confirmed this ...

EVERSANA has signed an agreement with Oracle Argus Cloud to add to the features of its pharmacovigilance platform, which ...

Artificial intelligence (AI) is an increasingly valuable tool in our perpetual quest for the miracles that science regularly ...

At LSX 2024 in Boston last month, editor-in-chief Jonah Comstock spoke with James Graham, CEO and founder of Recce Pharma, an ...

Embarking on the journey of a medical start-up is like navigating a complex labyrinth, where the final prize is the coveted ...

In our penultimate video from ESMO 2024, pharmaphorum spoke with Dr Magda Meissner, consultant medical oncologist at the ...

GSK said it expects to take a charge of £1.8 billion ($2.3 billion) in its third-quarter results in relation to the ...